Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Express Scripts
McKesson
Deloitte
Daiichi Sankyo
Colorcon
Fuji
Covington

Generated: October 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206551

« Back to Dashboard

NDA 206551 describes BIVALIRUDIN, which is a drug marketed by Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Hospira Inc, Mylan Institutional, Sagent Pharms, and Baxter Hlthcare Corp, and is included in ten NDAs. It is available from six suppliers. Additional details are available on the BIVALIRUDIN profile page.

The generic ingredient in BIVALIRUDIN is bivalirudin. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.
Summary for 206551
Tradename:BIVALIRUDIN
Applicant:Accord Hlthcare
Ingredient:bivalirudin
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength250MG/VIAL
Approval Date:Nov 22, 2017TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Queensland Health
Dow
UBS
Citi
Deloitte
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.